The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol

Mohammad Tallouzi, David Moore, Melanie Calvert, Philip Murray, Nick Bucknall, Alastair Denniston

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
143 Downloads (Pure)


Macular oedema (MO) describes the accumulation of fluid in the central part of the retina, known as the ‘macula’ which provides central vision. MO is the leading cause of sight loss in patients with intraocular inflammation (uveitis). There is a lack of consensus over the treatment of uveitic macular oedema (UMO). The proposed systematic review will evaluate the evidence on the effectiveness of pharmacological agents used to treat UMO. All systemic, local, or topical pharmacological agents will be included.

Standard systematic review methodology will be employed to identify, select and extract data from comparative studies (randomised/non-randomised trials and observational studies) of the pharmacological interventions in patients with UMO. Searches will be conducted through bibliographic databases (Cochrane Library, MEDLINE, EMBASE and CINAHL) and clinical trials registers. No restriction will be placed on either language or year of publication. Translation of non-English language articles will be undertaken to minimise selection bias. The primary outcome of interest will be best corrected visual acuity and secondary outcomes will be adverse events, health-related quality of life, assessment of UMO using central macular thickness (e.g. by optical coherence topography (OCT)), clinical and angiographic assessment of UMO, clinical estimation of vitreous haze. Risk of bias assessment appropriate to each study design will be undertaken. Data will be grouped by comparison, tabulated and narratively synthesised. Meta-analysis will be undertaken where clinical and methodological homogeneity exists. Subgroup and sensitivity analyses, also network analyses and intra/inter-pharmacological class analyses will be undertaken where deemed appropriate.

A number of published studies have investigated the effectiveness of the pharmacological agents used to treat UMO. However, there is no recent systematic review that synthesises this evidence. This systematic review will analyse the effectiveness of systemic, local and topical therapies to treat UMO. The findings will provide important evidence to inform clinical and health policy decision-making for the treatment of UMO.

Systematic review registration
Prospero CRD42015019170
Original languageEnglish
Article number29
JournalBMC Systematic Reviews
Issue number1
Publication statusPublished - 13 Feb 2016


  • Systematic review
  • Macular oedema
  • Macular edema
  • Uveitis
  • Management
  • Pharmacological agents
  • Meta-analysis


Dive into the research topics of 'The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol'. Together they form a unique fingerprint.

Cite this